Skip to main content

Peer Review Committee for Experimental Therapeutics (ET)

Areas Reviewed

  • Isolation, testing, and synthesis of natural products

  • Modification and development of drugs

  • Toxicity and effectiveness of therapeutic agents and drug delivery systems (including nanotechnology and microbial strategies)

  • Molecular imaging for pre-clinical therapeutic development

  • Pharmacology/pharmacogenetics/pharmacogenomics

  • Gene therapies and gene target validation

Peer Review Committee Members

Co-chair, Weibo Cai, PhD, University of Wisconsin Madison
Co-chair, Goutham Narla, MD, PhD, University of Michigan
Stakeholder, Elizabeth Naylor
Stakeholder, Nick Wendell
Raman Bahal, PhD, University of Connecticut
Chandra Bartholomeusz, MD, PhD, MD Anderson
Tomasz Cierpicki, PhD, University of Michigan
Edith Phoebe Glazer, PhD, North Carolina State University
Hanna Irie, MD, PhD, Mount Sinai
Dan Siegwart, PhD, UT Southwestern
Stavroula Sofou, PhD, Johns Hopkins University
Stephen Sykes, PhD, Washington University St. Louis
Uttam Tambar, PhD, UT Southwestern
Matt VanBrocklin, PhD, University of Utah
David Wald, MD, PhD, Case Western University